Zobrazeno 1 - 10
of 33
pro vyhledávání: '"MSCs, mesenchymal stromal cells"'
Autor:
Elizaveta Voynova, Konstantin Kulebyakin, Olga Grigorieva, Ekaterina Novoseletskaya, Natalia Basalova, Natalia Alexandrushkina, Mikhail Arbatskiy, Maxim Vigovskiy, Anna Sorokina, Anna Zinoveva, Elizaveta Bakhchinyan, Natalia Kalinina, Zhanna Akopyan, Vsevolod Tkachuk, Pyotr Tyurin-Kuzmin, Anastasia Efimenko
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
Externí odkaz:
https://doaj.org/article/a0afd3d86a014e64808b18d7f7f29b07
Autor:
Elizaveta Voynova, Konstantin Kulebyakin, Olga Grigorieva, Ekaterina Novoseletskaya, Natalia Basalova, Natalia Alexandrushkina, Mikhail Arbatskiy, Maxim Vigovskiy, Anna Sorokina, Anna Zinoveva, Elizaveta Bakhchinyan, Natalia Kalinina, Zhanna Akopyan, Vsevolod Tkachuk, Pyotr Tyurin-Kuzmin, Anastasia Efimenko
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Multipotent mesenchymal stromal cells (MSCs) maintain cellular homeostasis and regulate tissue renewal and repair both by differentiating into mesodermal lineage, e.g., adipocytes, or managing the functions of differentiated cells. Insulin is a key p
Externí odkaz:
https://doaj.org/article/882c477125b844d686ebaf243b5cf516
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Human mesenchymal stem cells (hMSCs) are the most commonly-tested adult stem cells in cell therapy. While the initial focus for hMSC clinical applications was to exploit their multi-potentiality for cell replacement therapies, it is now apparent that
Externí odkaz:
https://doaj.org/article/66aa1b796ff84b0ea22d513a08d88359
Autor:
Joana R. Ferreira, Graciosa Q. Teixeira, Susana G. Santos, Mário A. Barbosa, Graça Almeida-Porada, Raquel M. Gonçalves
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Mesenchymal stromal cells (MSCs) are self-renewing, culture-expandable adult stem cells that have been isolated from a variety of tissues, and possess multipotent differentiation capacity, immunomodulatory properties, and are relatively non-immunogen
Externí odkaz:
https://doaj.org/article/42ff91bed4174780a337cffb32199d0a
Publikováno v:
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 11, Iss 6, Pp 1493-1512 (2021)
Acta Pharmaceutica Sinica B, Vol 11, Iss 6, Pp 1493-1512 (2021)
Macrophages are typically identified as classically activated (M1) macrophages and alternatively activated (M2) macrophages, which respectively exhibit pro- and anti-inflammatory phenotypes, and the balance between these two subtypes plays a critical
Publikováno v:
EFORT Open Reviews
Multifactorial aetiology defines non-unions, with a biological and a mechanical distortion of the timeline of bone healing. Research on new advances to increase osteogenesis and promote non-union healing is strongly directed towards new forms of cell
Autor:
Chikage Shirakawa, Natsuki Komori, Fujita Yasutaka, Taichi Takenawa, Tamaki Wada, Osamu Sawamoto, Masuhiro Nishimura, Masako Doi
Publikováno v:
Regenerative Therapy
Regenerative Therapy, Vol 14, Iss, Pp 95-102 (2020)
Regenerative Therapy, Vol 14, Iss, Pp 95-102 (2020)
Introduction Stem cells for therapy are often suspended in a preservation solution, such as normal saline or lactated Ringer's solution, for a short time before intravenous infusion. However, these solutions are not necessarily ideal for maintaining
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Xiangyang Qin, Dandan Yin, Wen Yin, Xingbin Hu, Jing Yi, Shouwen Chen, Qunxing An, Ning An, Fan Feng, Yaozhen Chen, Lihong Weng, Zheng Liu
Publikováno v:
EBioMedicine
EBioMedicine, Vol 32, Iss, Pp 31-42 (2018)
EBioMedicine, Vol 32, Iss, Pp 31-42 (2018)
Mesenchymal stromal cells (MSCs) based therapy is a promising approach to treat inflammatory disorders. However, therapeutic effect is not always achieved. Thus the mechanism involved in inflammation requires further elucidation. To explore the mecha
4-Phenylbutyric acid enhances the mineralization of osteogenesis imperfecta iPSC-derived osteoblasts
Autor:
Shinji Takeyari, Kazunori Mizuno, Makoto Fujiwara, Yasuhisa Ohata, Yuki Taga, Keiichi Ozono, Taichi Kitaoka, Takuo Kubota
Publikováno v:
The Journal of Biological Chemistry
Osteogenesis imperfecta (OI) is a heritable brittle bone disease mainly caused by mutations in the two type I collagen genes. Collagen synthesis is a complex process including trimer formation, glycosylation, secretion, extracellular matrix (ECM) for